(Q33235431)

English

[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 July 2017

[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study (English)

1 reference

Europe PubMed Central

24 July 2017

Adaptive radiation therapy

0 references

feasibility study

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bernd Gagel

1

1 reference

Europe PubMed Central

24 July 2017

Patrick Reinartz

2

1 reference

Europe PubMed Central

24 July 2017

Cengiz Demirel

3

1 reference

Europe PubMed Central

24 July 2017

Hans J Kaiser

4

1 reference

Europe PubMed Central

24 July 2017

Michael Zimny

5

1 reference

Europe PubMed Central

24 July 2017

Marc Piroth

6

1 reference

Europe PubMed Central

24 July 2017

Michael Pinkawa

7

1 reference

Europe PubMed Central

24 July 2017

Sven Stanzel

8

1 reference

Europe PubMed Central

24 July 2017

Branka Asadpour

9

1 reference

Europe PubMed Central

24 July 2017

Kurt Hamacher

10

1 reference

Europe PubMed Central

24 July 2017

Heinz H Coenen

11

1 reference

Europe PubMed Central

24 July 2017

Ulrich Buell

12

1 reference

Europe PubMed Central

24 July 2017

Michael J Eble

13

1 reference

Europe PubMed Central

24 July 2017

language of work or name

0 references

publication date

4 March 2006

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

6

1 reference

Europe PubMed Central

24 July 2017

51

1 reference

Europe PubMed Central

24 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-6-51

0 references

Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456976

14 July 2018

Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? The EC PET Oncology Concerted Action and the EORTC PET Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456976

14 July 2018

Nitroimidazoles and imaging hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456976

14 July 2018

Determination of 2-fluoro-2-deoxy-D-glucose uptake and ATP level for evaluating drug effects in neoplastic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456976

14 July 2018

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Predicting the effect of temporal variations in PO2 on tumor radiosensitivity.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

High-tech will improve radiotherapy of NSCLC: a hypothesis waiting to be validated.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Hemoglobin as an Independent Prognostic Factor in the Radiotherapy of Head and Neck Tumors

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Erythropoietin restores the anemia-induced reduction in radiosensitivity of experimental human tumors in nude mice.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-51

21 January 2018

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1456976

31 October 2018

Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapeutic Management of Head and Neck Malignancies With Positron Emission Tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[18F-fluorodeoxyglucose PET in ovarian carcinoma: methodology and preliminary results]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring liver tumor therapy with [18F]FDG positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix

1 reference

https://pubmed.ncbi.nlm.nih.gov/16515707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-6-51

1 reference

Europe PubMed Central

24 July 2017

Dimensions Publication ID

0 references

release_hkgj2u4j6jg5tf6mbjvo566vn4

1 reference

https://api.fatcat.wiki/v0/release/hkgj2u4j6jg5tf6mbjvo566vn4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

24 July 2017

1 reference

Europe PubMed Central

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33235431&oldid=1842505653"